David J. Begley

Flavonoid permeability across an in situ model of the blood–brain barrier

Kuresh Youdim, M. Zeeshan Qaiser, David J. Begley et al. · Free Radical Biology and Medicine · 2003 · 585 citations

Flavonoid Permeability, Blood–brain Barrier, Situ Model +9

Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles

Jörg Kreuter, Peter Ramge, Stefan Hamm et al. · Pharmaceutical Research · 2003 · 464 citations

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Anja Zensi, David J. Begley, Charles Pontikis et al. · Journal of Controlled Release · 2009 · 426 citations

Nanomedicine, Engineering, Apo E +6

Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction

Scott Summerfield, Kevin D. Read, David J. Begley et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 279 citations

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: An<i>in situ</i>brain perfusion study

R. N. Alyautdin, E. B. Tezikov, Peter Ramge et al. · Journal of Microencapsulation · 1998 · 232 citations